Ipremom, a Spanish startup building tools to identify risks of future complications for mothers in the early stages of pregnancy, has raised a €15m seed round. The funding round was led by unnamed investors. The company aims to improve maternal health outcomes through early detection technology.

Ipremom's solution focuses on identifying risks during the early stages of pregnancy to enable preventative care. The seed capital will support further development and expansion of their femtech platform.